Oxford University is conducting a nationwide drugs trial which could prevent people aged over 50 who are vulnerable to developing serious Covid-19 symptoms and is recruiting now.
Using drugs that have treated malaria and arthritis, the Platform Randomised trial of Interventions against COVID-19 in Older peoPLE (PRINCIPLE) trial is testing the pre-existing medication hydroxychloroquine in the first phase over a seven-day course.